Ella Therapeutics

Microbiome-based Products for Combination Therapy with Immuno-oncology

Health Tech & Life Sciences
Non Active, Jul 2022 ceased to operate
Pre-Funding Ramat Gan Founded 2019
Total raised
Stage
Pre-Funding
Founded
2019
Headcount
1-10
HQ
Ramat Gan
Sector
Health Tech & Life Sciences

About

Ella Therapeutics is developing microbiome-based products for combination therapy with immuno-oncology. Ella Therapeutics' mission is to overcome immunotherapy resistance in cancer patients through alteration of the gut microbiome via engineered bacteria or a live biotherapeutic product. The company's platform is for all major cancer indications and was developed with the aim of saving lives that were otherwise lost due to patients' bodies' resistance to medicine.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

oncologycancermicrobiomeimmunotherapybiopharmaceuticalbioinformaticsbiotechnology